Source:http://linkedlifedata.com/resource/pubmed/id/10695487
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2000-3-22
|
pubmed:abstractText |
Lipid-lowering therapy leads to a great reduction of cardiovascular complications, but has almost no effect on the degree of stenosis of coronary arteries. These and other studies have lead to a new paradigm of coronary artery disease, i. e. clinical prognosis is not only determined by the extent of a single stenosis, but mainly by the number and structure of atherosclerotic plaques. Rupture of an instable or vulnerable plaque, characterized by a large lipid-rich central core, inflammatory cells, and a thin fibrous cap, causes sudden thrombus formation and thereby acute coronary syndromes. There is accumulating evidence that cholesterol lowering can result in plaque stabilization and improvement of endothelial dysfunction.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0340-6245
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
82 Suppl 1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
60-1
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading | |
pubmed:year |
1999
|
pubmed:articleTitle |
Lipid lowering therapy and stabilization of atherosclerotic plaques.
|
pubmed:affiliation |
Klinik II und Poliklinik für Innere Medizin, University of Cologne, Germany.
|
pubmed:publicationType |
Journal Article,
Review
|